Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Howtian is a global leader in the production of natural sweeteners and functional ingredients, most notably recognized as one of the world's largest manufacturers of stevia extracts. Formerly known as Zhucheng Haotian Pharm, the company rebranded to Howtian in 2022 to reflect its evolution into a comprehensive health and wellness solutions provider. Their product portfolio includes high-purity stevia, inositol, and pyrroloquinoline quinone (PQQ), serving the food, beverage, and pharmaceutical industries. Howtian operates a vertically integrated supply chain, from seedling cultivation to large-scale manufacturing, ensuring sustainability and quality control. The company focuses on providing sugar-reduction solutions and functional nutrition to address global health challenges like obesity and diabetes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Howtian.